Cytek BioSciences 

$4.81
29
+$0.15+3.22% Friday 20:00
-$0.25-5.2%Friday 22:21After hours

Statistics

Day High
4.83
Day Low
4.8
52W High
6.18
52W Low
3.28
Volume
37,263
Avg. Volume
-
Mkt Cap
625.22M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.15
-0.06
0.03
0.12
Expected EPS
-0.07
Actual EPS
N/A

Financials

-33.02%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
201.49MRevenue
-66.54MNet Income

Analyst Ratings

5.13Average Price Target
The highest estimate is 5.50.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CTKB. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biodesix
BDSX
Mkt Cap253.23M
Biodesix is a competitor because it also operates in the biotechnology sector focusing on diagnostic solutions, similar to Cytek's focus on cell analysis technologies.
Guardant Health
GH
Mkt Cap21.1B
Guardant Health operates in the precision oncology field, offering liquid biopsies and cancer diagnostics that compete with Cytek's diagnostic solutions.
Illumina
ILMN
Mkt Cap28.82B
Illumina, Inc. competes with Cytek through its next-generation sequencing (NGS) technologies, which are used in genetic analysis and overlap with Cytek's cell analysis market.
Pacific Biosciences of California
PACB
Mkt Cap357.46M
Pacific Biosciences of California offers long-read sequencing technologies, competing in the broader genomics and cell analysis market that Cytek targets.
Qiagen NV
QGEN
Mkt Cap8.87B
QIAGEN N.V. provides sample and assay technologies for molecular diagnostics, competing with Cytek in the life sciences and molecular diagnostics sectors.
Thermo Fisher Scientific
TMO
Mkt Cap217.52B
Thermo Fisher Scientific offers a wide range of analytical instruments and reagents, including those for cell analysis, directly competing with Cytek's product offerings.
Danaher
DHR
Mkt Cap142.32B
Danaher Corporation, through its Life Sciences segment, offers products and services that compete with Cytek's cell analysis and cytometry solutions.
Agilon Health
AGL
Mkt Cap1.63B
Agilent Technologies provides instruments, services, and consumables for laboratories, including cell analysis technologies that compete with Cytek BioSciences.

About

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Show more...
CEO
Wenbin Jiang
Employees
702
Country
United States
ISIN
US23285D1090
WKN
000A3CVW1

Listings

0 Comments

Share your thoughts

FAQ

What is Cytek BioSciences stock price today?
The current price of CTKB is $4.81 USD — it has increased by +3.22% in the past 24 hours. Watch Cytek BioSciences stock price performance more closely on the chart.
What is Cytek BioSciences stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Cytek BioSciences stocks are traded under the ticker CTKB.
Is Cytek BioSciences stock price growing?
CTKB stock has risen by +2.56% compared to the previous week, the month change is a +5.95% rise, over the last year Cytek BioSciences has showed a +15.9% increase.
What is Cytek BioSciences market cap?
Today Cytek BioSciences has the market capitalization of 625.22M
When is the next Cytek BioSciences earnings date?
Cytek BioSciences is going to release the next earnings report on November 11, 2026.
What were Cytek BioSciences earnings last quarter?
CTKB earnings for the last quarter are -0.09 USD per share, whereas the estimation was -0.09 USD resulting in a +3.57% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cytek BioSciences revenue for the last year?
Cytek BioSciences revenue for the last year amounts to 201.49M USD.
What is Cytek BioSciences net income for the last year?
CTKB net income for the last year is -66.54M USD.
How many employees does Cytek BioSciences have?
As of August 22, 2026, the company has 702 employees.
In which sector is Cytek BioSciences located?
Cytek BioSciences operates in the Health & Wellness sector.
When did Cytek BioSciences complete a stock split?
Cytek BioSciences has not had any recent stock splits.
Where is Cytek BioSciences headquartered?
Cytek BioSciences is headquartered in FREMONT, United States.